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Do adults with bacterial infections
develop less of an antibiotic resistance
with IV antibiotics after a full course of treatment?
Taylor-Erin Evitts and Navvy Stevens
Abstract

Evaluation & Analysis

This study was conducted in order to discover if
patients develop less of an antibiotic resistance when going
through intravenous antibiotics, compared to using oral
antibiotics. This concept was created due to the fact that many
people that are prescribed oral antibiotics, do not finish the
entire prescribed amount. When this occurs, it gives the bacteria
that the antibiotics were trying to get rid of, have the chance to
adapt and become resistant to the particular antibiotic. By
discovering the percentage of people who were prescribed
antibiotics that never finished a round of them, it aids in
narrowing down what the best course of action would be to aid
in further preventing the spread of antibiotic resistance.

McCarthy & Avent (2020) found that the overuse of antibiotics has contributed to the
emergence and dissemination of antimicrobial-resistant nosocomial and community
pathogens. Reducing intravenous antibiotic use and shortening the duration of antibiotic
courses can contribute to less antibiotic use overall, reducing the development of antibiotic
resistance. The appropriate use of oral antibiotics, especially those with good bioavailability,
is also essential to maintain their usefulness.
Throughout the history of antibiotic use, recommendations on duration of therapy were
based on fairly arbitrary extension of days of treatment such as 7, 10, or 14 days rather than
on reliable evidence with the main aim to keep the risk of failures and undertreatment at a
minimum. This concept, before the gradual increase in the incidence of antibiotic-resistant
infections, was utilized to treat beyond clinical improvement to accomplish both the desire
to reduce relapses and the belief that antimicrobial resistance could be prevented by a
prolonged antibiotic course.
The use of IV antibiotics has shown correlation to a rise in antibiotic-resistant
infections. As antibiotic resistance has increased, our ability to use oral antibiotics to treat
infections has declined. Infections that generally would not require intravenous antibiotics
now often do (Johnson, 2017). Broad-spectrum antibiotics are more likely to lead to
bacteria that resist drugs. This leads to infections that last longer and cost more to treat.
They can spread to family and friends. Reducing the dosage of antibiotics is called “deescalation” used to improve treatment and help prevent antibiotic overuse (“Antibiotic
Treatment in the Hospital”, 2016).
There is also a belief among doctors and some patients that intravenous antibiotics can
hold “additional potency” (Broom et al., 2016) is an important misunderstanding given that
clinical evidence supports efficacy of oral formulations in many common clinical situations.
This hesitation to use an oral route despite evidence of clinical efficacy has shown
persistence over time and across different specialty areas, despite the preference of patients
for outpatient management with oral antibiotics. This can impact the intravenous to oral
switch method and also lead to intravenous overuse, a major factor in the development of
antibiotic resistance.
From the data collected from the online poll, it was discovered that while 92.8% of the
69 people that completed the poll have been prescribed oral antibiotics at one point in their
lives, only about 65.2% of people have actually completely finished taking the prescribed
amount. While a good amount of antibiotic resistance comes from overuse of strong
antibiotics that the bacteria can adapt to, it also comes from not taking the entire amount of
the prescribed oral antibiotics. This is why it was believed that IV antibiotics may be a
better way to administer antibiotics, to be able to fully ensure that the entire prescribed
amount is taken.
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Introduction
Antibiotics are used to help treat infections with an intravenous or oral route of
administration. Intravenous antibiotics can be used for severe infections, like sepsis, in order
to reach the tissues faster and with a higher concentration compared to oral antibiotics. It is
also more penetrable in parts of the body such as in the bone and spinal fluid where oral
methods are not as effective (Johnson, 2017).

Conclusion & Implications for Future
Research

Antibiotics are given to help treat the infection as quickly as possible, in which the health
care provider may give more than one at a time or a “broad-spectrum” antibiotic to kill many
types of bacteria (“Antibiotic Treatment in the Hospital”, 2016). Unfortunately, the influence
of antibiotics is now fading due to the progressive rise of resistance, and this phenomenon is
observed among all antimicrobial drugs.The first sign of antibiotic resistance was discovered
by Abraham and Chain in 1940 when they reported an E. coli strain was able to inactivate
penicillin by producing penicillinase (Lobanovska & Pilla, 2017).
Antibiotic resistance is a dangerous problem rising to a high level in today’s healthcare.
New resistance mechanisms are emerging and spreading globally, threatening our ability to
treat common infectious diseases. Specific infections such as pneumonia, tuberculosis, blood
poisoning, gonorrhoea, and foodborne diseases are proving to becoming harder, and
sometimes impossible, to treat as antibiotics become less effective.While there are specific
bacteria that are resistant to antibiotics, many times people can resistant to antibiotics over
time if they are misused, especially with certain forms of administration such as intravenous
(“Antibiotic Resistance”, 2020).
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Methods
A
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A literature review involving relevant data to the research topic from scholarly articles
and other sources was conducted. Five sources were peer-reviewed, primary articles from
scholarly journals published within the last five years. The other three were educational
sources from professional websites and other scientific literature.
A poll was created through “Google Forms” and shared on Facebook to get responses
from a variety of individuals. There were three questions asked, only one being required
because the other two questions were only for the individuals that answered “Yes” to the
first question. The amount of responses received from the he poll was 72, however only 69
people responded to all three questions. With the questions being “Have you ever been
prescribed antibiotics?” being the first question asked, it set up a basis for the next two
questions. If the individual answered “Yes” to the question of if they had ever been
prescribed antibiotics, then they would answer the second question, that being “If you
answered “yes” to the previous questions, were the antibiotics oral or administered via IV?”.
If the individual answered “Oral” or “Both”, they were directed to the third question of “If
you have been prescribed ORAL antibiotics, have you always completely finished all of the
prescribed amount?”. These questions were prompted in this way in order to narrow down
the answers for the data that was trying to be collected, that of what percentage of people in
the sample have not finished all of their prescribed oral antibiotics at any given time.
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McCarthy & Avent (2020) suggested shorter durations of intravenous antibiotic therapy and
switching to oral therapy are important considerations in patient management. These interventions
have the potential to improve outcomes for patients by avoiding the adverse effects of intravenous
drugs and may facilitate early discharge from hospital.
The intravenous to oral switch method should to “demystify antibiotic efficacy, engage consumers
around the negative effects of iv antibiotic overuse and examine strategies to streamline team
decision-making” (“Antibiotic Resistance”, 2020). Addressing these issues can effectively reduce
inappropriate antibiotic use that can lead to resistance. If key limiting factors to early oral switch
are identified, this modification can allow programs to develop a more widely applicable and
accessible base.
Lobanovska & Pilla (2017) indicated a need for new techniques for rapid diagnostics of
bacterial infection and better antibiotic surveillance schemes to be designed, as they are crucial for
early identification of resistance and the implementation of appropriate interventions to combat
the spread of antibiotic resistance. With more and more bacteria adapting to become resistant to
antibiotics each year, the numbers for individuals getting antibiotic resistant infections raise
greater and faster. If something is not done to adapt new antibiotic agents in the near future, the
crisis will get worse.
It is also important as the healthcare professionals to help prevent and control the spread of
antibiotic resistance with ensuring appropriate hand hygiene, only administering prescribed
antibiotics as they are needed, report any antibiotic-resistant infections, and educating the patient
on correct administration, antibiotic restitanse, the dangers of misuse, and preventing infections
(“Antibiotic Resistance”, 2020).
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